Finished
Feasibility and Safety of a Portable Exoskeleton to Improve Mobility in Parkinson's Disease
NCT06028529 · VA Office of Research and Development · Updated 7 Oct 2026
- What is being tested
- Exoskeleton
- For
- Parkinson's Disease
- Kind of study
- Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
- Who can join
- Ages 18 years to 90 years. About 10 people. The full rules are on the registry page.
- Where
- United States
- When
- Starts or started 1 Sept 2024, ends 25 Feb 2026. Registered 8 Sept 2023.
- Results
- None posted yet.
In the researchers' words
Physical therapy approaches for balance and walking deficits in Parkinson's disease (PD) have limited effectiveness, with mostly short-lasting benefits. An exoskeleton is a device that straps to the legs and provides a passive force to assist people to better ambulate. The goal of this study is to establish the feasibility and safety of a lightweight exoskeleton on mobility and fall reduction in people with PD. As most PD patients eventually require assistive mobility devices, the exoskeleton represents a new option for increased, mobility, quality of life, and independence. Qualified subjects will come to the clinic twice weekly for eight weeks (16 total visits) and wear the exoskeleton device while walking under the supervision of a trained kinesiotherapist. Study staff will also interview participants and assess their PD symptoms, quality of life, and overall mobility. This study hopes to establish exoskeletons as modern, standard of care devices, which allow people with PD to maintain more independent and productive lives.
Sites
- Richmond VA Medical Center, Richmond, VARichmond, Virginia, United States
